Obesity and novel cardiovascular markers in a population without diabetes and cardiovascular disease in China

Preventive Medicine

Volumn 91, Issue , 2016, Pages 62-69

  Zeng, Qiang ^a   Dong, Sheng Yong ^b   Wang, Man Liu ^c   Li, Jin Ming ^b   Ren, Chong Lei ^a   Gao, Chang Qing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Agency for Offices Administration of PLA   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

Cardiovascular marker; Metabolic syndrome; Obesity; Pulse wave velocity; Troponin T

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY FAT; BODY MASS; BRACHIAL ANKLE PULSE WAVE VELOCITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE PRESSURE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO; ANKLE BRACHIAL INDEX; BLOOD; BLOOD PRESSURE; MIDDLE AGED; QUESTIONNAIRE;

ANKLE BRACHIAL INDEX; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHINA; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; SURVEYS AND QUESTIONNAIRES; TROPONIN T;

EID: 84981163087     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2016.08.001     Document Type: Article

References (38)

1. Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., Fruchart, J.C., James, W.P., Loria, C.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (2009), 1640–1645.
2. Amato, M.C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., AlkaMeSy Study, G., Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33 (2010), 920–922.
3. Apovian, C.M., Gokce, N., Obesity and cardiovascular disease. Circulation 125 (2012), 1178–1182.
4. Arnlov, J., Ingelsson, E., Sundstrom, J., Lind, L., Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121 (2010), 230–236.
5. Bayes-Genis, A., DeFilippi, C., Januzzi, J.L. Jr., Understanding amino-terminal pro-B-type natriuretic peptide in obesity. Am. J. Cardiol. 101 (2008), 89–94.
6. Bhaskaran, K., Douglas, I., Forbes, H., dos-Santos-Silva, I., Leon, D.A., Smeeth, L., Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384 (2014), 755–765.
7. Calori, G., Lattuada, G., Piemonti, L., Garancini, M.P., Ragogna, F., Villa, M., Mannino, S., Crosignani, P., Bosi, E., et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona study. Diabetes Care 34 (2011), 210–215.
8. D'Angelo, G., Weissfeld, L., Gen, I.M.S.I., An index approach for the Cox model with left censored covariates. Stat. Med. 27 (2008), 4502–4514.
9. Du, T., Zhang, J., Yuan, G., Zhang, M., Zhou, X., Liu, Z., Sun, X., Yu, X., Nontraditional risk factors for cardiovascular disease and visceral adiposity index among different body size phenotypes. Nutr. Metab. Cardiovasc. Dis. 25 (2015), 100–107.
10. Fernandez-Friera, L., Penalvo, J.L., Fernandez-Ortiz, A., Ibanez, B., Lopez-Melgar, B., Laclaustra, M., Oliva, B., Mocoroa, A., Mendiguren, J., et al. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (Progression of Early Subclinical Atherosclerosis) study. Circulation 131 (2015), 2104–2113.
11. Fitchett, D., The metabolic syndrome is an important concept in therapeutic decision-making. Can. J. Cardiol. 31 (2015), 596–600.
12. Global Burden of Metabolic Risk Factors for Chronic Diseases, C., Lu, Y., Hajifathalian, K., Ezzati, M., Woodward, M., Rimm, E.B., Danaei, G., Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 383 (2014), 970–983.
13. Gustafson, B., Smith, U., Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk. Atherosclerosis 241 (2015), 27–35.
14. Hamer, M., Stamatakis, E., Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 97 (2012), 2482–2488.
15. Heymsfield, S.B., Cefalu, W.T., Does body mass index adequately convey a patient's mortality risk?. JAMA 309 (2013), 87–88.
16. Kaess, B.M., Rong, J., Larson, M.G., Hamburg, N.M., Vita, J.A., Levy, D., Benjamin, E.J., Vasan, R.S., Mitchell, G.F., Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 308 (2012), 875–881.
17. Kuk, J.L., Ardern, C.I., Are metabolically normal but obese individuals at lower risk for all-cause mortality?. Diabetes Care 32 (2009), 2297–2299.
18. Luna-Luna, M., Medina-Urrutia, A., Vargas-Alarcon, G., Coss-Rovirosa, F., Vargas-Barron, J., Perez-Mendez, O., Adipose tissue in metabolic syndrome: onset and progression of atherosclerosis. Arch. Med. Res. 46 (2015), 392–407.
19. Neeland, I.J., Drazner, M.H., Berry, J.D., Ayers, C.R., deFilippi, C., Seliger, S.L., Nambi, V., McGuire, D.K., Omland, T., et al. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J. Am. Coll. Cardiol. 61 (2013), 187–195.
20. Neeland, I.J., Winders, B.R., Ayers, C.R., Das, S.R., Chang, A.Y., Berry, J.D., Khera, A., McGuire, D.K., Vega, G.L., et al. Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile. J. Am. Coll. Cardiol. 62 (2013), 752–760.
21. Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E.C., Biryukov, S., Abbafati, C., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
22. Ning, X., Zhan, C., Yang, Y., Yang, L., Tu, J., Gu, H., Su, T.C., Wang, J., Secular trends in prevalence of overweight and obesity among adults in rural Tianjin, China from 1991 to 2011: a population-based study. PLoS One, 9, 2014, e116019.
23. Romero-Corral, A., Somers, V.K., Sierra-Johnson, J., Korenfeld, Y., Boarin, S., Korinek, J., Jensen, M.D., Parati, G., Lopez-Jimenez, F., Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur. Heart J. 31 (2010), 737–746.
24. Rothman, K.J., BMI-related errors in the measurement of obesity. Int. J. Obes. 32:Suppl. 3 (2008), S56–S59.
25. Saunders, J.T., Nambi, V., de Lemos, J.A., Chambless, L.E., Virani, S.S., Boerwinkle, E., Hoogeveen, R.C., Liu, X., Astor, B.C., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 123 (2011), 1367–1376.
26. Shah, R., Gayat, E., Januzzi, J.L. Jr., Sato, N., Cohen-Solal, A., Disomma, S., Fairman, E., Harjola, V.P., Ishihara, S., et al. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J. Am. Coll. Cardiol. 63 (2014), 778–785.
27. Thompson, A.M., Zhang, Y., Tong, W., Xu, T., Chen, J., Zhao, L., Kelly, T.N., Chen, C.S., Bazzano, L.A., et al. Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China. Int. J. Cardiol. 150 (2011), 247–252.
28. Tobias, D.K., Pan, A., Jackson, C.L., O'Reilly, E.J., Ding, E.L., Willett, W.C., Manson, J.E., Hu, F.B., Body-mass index and mortality among adults with incident type 2 diabetes. N. Engl. J. Med. 370 (2014), 233–244.
29. Turer, A.T., Hill, J.A., Elmquist, J.K., Scherer, P.E., Adipose tissue biology and cardiomyopathy: translational implications. Circ. Res. 111 (2012), 1565–1577.
30. Twig, G., Yaniv, G., Levine, H., Leiba, A., Goldberger, N., Derazne, E., Ben-Ami Shor, D., Tzur, D., Afek, A., et al. Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N. Engl. J. Med., 2016, 10.1056/NEJMoa1503840.
31. Wang, Y., He, Y., Jiang, B., Wang, J., Wu, L., Liu, M., Sun, D., Li, X., Yang, S., Study on the secular changes of BMI, prevalence rates of overweight, obesity and related factors in an urban elderly population, Beijing from 2001 to 2010. Zhonghua Liu Xing Bing Xue Za Zhi 35 (2014), 359–364.
32. Welsh, P., Doolin, O., Willeit, P., Packard, C., Macfarlane, P., Cobbe, S., Gudnason, V., Di Angelantonio, E., Ford, I., et al. N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. Eur. Heart J. 34 (2013), 443–450.
33. Wildman, R.P., Muntner, P., Reynolds, K., McGinn, A.P., Rajpathak, S., Wylie-Rosett, J., Sowers, M.R., The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch. Intern. Med. 168 (2008), 1617–1624.
34. Wormser, D., Kaptoge, S., Di Angelantonio, E., Wood, A.M., Pennells, L., Thompson, A., Sarwar, N., Kizer, J.R., Lawlor, D.A., et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 377 (2011), 1085–1095.
35. Zeng, Q., Dong, S.Y., Sun, X.N., Xie, J., Cui, Y., Percent body fat is a better predictor of cardiovascular risk factors than body mass index. Braz. J. Med. Biol. Res. 45 (2012), 591–600.
36. Zeng, Q., Dong, S.Y., Song, Z.Y., Zheng, Y.S., Wu, H.Y., Mao, L.N., Ideal cardiovascular health in Chinese urban population. Int. J. Cardiol. 167 (2013), 2311–2317.
37. Zeng, Q., Dong, S.Y., Wang, M.L., Xiang, H., Zhao, X.L., Association of EZSCAN values with arterial stiffness in individuals without diabetes or cardiovascular disease. PLoS One, 9, 2014, e90854.
38. Zhou, B.F., Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 15 (2002), 83–96.